Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods

International Journal of Cardiology

Volumn 99, Issue 2, 2005, Pages 283-287

  Naegeli, Barbara ^a   Straumann, Edwin ^a   Bertel, Osmund ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Atrial fibrillation; Cardioversion; Class III antiarrhythmic drugs; Ibutilide

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; IBUTILIDE; IBUTILIDE FUMARATE; SOTALOL;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT INTERVAL; SIDE EFFECT; SINUS RHYTHM; STROKE; TORSADE DES POINTES;

EID: 14644391594     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.01.020     Document Type: Article

References (25)

1. Oral H., Souza J.J., Michaud G.F., et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N. Engl. J. Med. 340:1999;1849-1854
2. Marcus G.M., Sung R.J. Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology. 95:2001;1-8
3. Li H., Natale A., Tomassoni G., et al. Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation. Am. J. Cardiol. 84:1999;1096-1098. [A10]
4. Lee K.S. Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J. Pharmacol. Exp. Ther. 262:1992;99-108
5. Glatter K., Yang Y., Chatterjee K., et al. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation. 103:2001;253-257
6. Neri R., Palermo P., Cesario A.S., Baragli D., Amici E., Gambelli G. Internal cardioversion of chronic atrial fibrillation in patients. Pacing Clin. Electrophysiol. 20:1997;2237-2242
7. Alt E., Ammer R., Schmitt C., et al. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur. Heart J. 18:1997;1796-1804
8. Schmitt C., Alt E., Plewan A., et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J. Am. Coll. Cardiol. 28:1996;994-999
9. Schmieder S., Schneider M.A., Karch M.R., Schmitt C. Internal low energy cardioversion of atrial fibrillation using a single lead system: comparison of a left and right pulmonary artery catheter approach. Pacing Clin. Electrophysiol. 24:2001;1108-1112
10. Abi-Mansour P., Carberry P.A., McCowan R.J., Henthorn R.W., Dunn G.H., Perry K.T. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators. Am. Heart J. 136:1998;632-642
11. Stambler B.S., Wood M.A., Ellenbogen K.A., Perry K.T., Wakefield L.K., VanderLugt J.T. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. 94:1996;1613-1621
12. Ellenbogen K.A., Stambler B.S., Wood M.A., et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J. Am. Coll. Cardiol. 28:1996;130-136
13. Volgman A.S., Carberry P.A., Stambler B., et al. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J. Am. Coll. Cardiol. 31:1998;1414-1419
14. Van Gelder I.C., Crijns H.J. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. Pacing Clin. Electrophysiol. 20:1997;2675-2683
15. Duytschaever M., Haerynck F., Tavernier R., Jordaens L. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation. Pacing Clin. Electrophysiol. 21:1998;284-287
16. Cooper R.A., Johnson E.E., Wharton J.M. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration. Circulation. 95:1997;1487-1496
17. Mansourati J., Larlet J.M., Salaun G., Maheu B., Blanc J.J. Safety of high energy internal cardioversion for atrial fibrillation. Pacing Clin. Electrophysiol. 20:1997;1919-1923
18. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 96:1997;2455-2461
19. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 89:1994;724-730
20. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., Rautaharju P.M. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am. J. Cardiol. 74:1994;236-241
21. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population based cohort. The Framingham Heart Study. JAMA. 271:1994;840-844
22. Mitchell L.B., Wyse D.G., Gillis A.M., Duff H.J. Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects. Circulation. 80:1989;34-42
23. Cui G., Sen L., Sager P., Uppal P., Singh B.N. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am. J. Cardiol. 74:1994;896-900
24. Antzelevitch C., Sicouri S. Clinical relevance of cardiac arrhythmias generated by after depolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J. Am. Coll. Cardiol. 23:1994;259-277
25. Murray K.T. Ibutilide. Circulation. 97:1998;493-497